Interictal psychoses in comparison with schizophrenia--a prospective study

Area of Science:

• Neuroscience
• Psychiatry
• Clinical Neurology

Background:

• Epilepsy is associated with a higher risk of developing psychosis.
• Interictal psychosis in epilepsy presents unique challenges in diagnosis and treatment.
• Understanding the differences between epilepsy-associated psychosis and primary psychotic disorders like schizophrenia is crucial for effective management.

Purpose of the Study:

• To determine the incidence of interictal psychosis in epilepsy patients.
• To compare the efficacy of antipsychotic drugs in epilepsy patients with interictal psychosis versus patients with schizophrenia.
• To analyze differences in psychotic states and treatment responses between these groups.

Main Methods:

• A prospective, two-part study involving 619 epilepsy patients for incidence and 182 patients with psychotic syndromes for treatment comparison.
• Included 59 patients with schizophrenia and 13 with epilepsy and interictal psychosis.
• Utilized the Positive and Negative Syndrome Scale (PANSS) for efficacy assessment.

Main Results:

• The annual incidence of interictal psychosis was 0.42%.
• Epilepsy patients with interictal psychosis showed significantly lower PANSS negative subscale scores initially and a trend towards better response to antipsychotics at one year (53.8% vs. 27.1%).
• Lower initial and maximum antipsychotic drug doses were required for epilepsy patients with interictal psychosis compared to schizophrenia patients.

Conclusions:

• Schizophrenia and epilepsy-associated psychosis exhibit distinct symptom profiles.
• Epilepsy patients with interictal psychosis demonstrated higher remission rates with lower antipsychotic drug doses over a one-year follow-up compared to schizophrenia patients.